DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/xvbswp/renal_failure) has announced the addition of the "Renal Failure Partnering 2009-2014" report to their offering.
The Renal Failure Partnering 2009-2014 provides understanding and access to the renal failure partnering deals and agreements entered into by the worlds leading healthcare companies.
This data driven report contains over 90 links to online copies of actual renal failure deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.
- Trends in renal failure dealmaking in the biopharma industry since 2009
- Access to summary headline, upfront, milestone and royalty data
- The leading renal failure deals by value since 2009
In Renal Failure Partnering 2009-2014, the available deals are listed by:
- Headline value
- Upfront payment value
- Royalty rate value
- Company A-Z
- Industry sector
- Stage of development at signing
- Deal component type
- Technology type
Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
For more information visit http://www.researchandmarkets.com/research/xvbswp/renal_failure